Loading company…
MetaSight Diagnostics develops blood tests for early disease detection and monitoring.
MetaSight Diagnostics uses high-throughput mass spectrometry and multi-omics analysis of blood samples to develop diagnostic and monitoring solutions. Founded in 2021, the company is based in Rehovot, Israel. In November 2024, it raised USD 8.000 mn in Series A funding from aMoon, Saban Ventures, ARC Ventures, and Alumni Ventures Group.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in